A 64-year-old man comes to the urgent care clinic due to the sudden onset of severe pain, … — USMLE Step 3

A 64-year-old man comes to the urgent care clinic due to the sudden onset of severe pain, swelling, and redness in his left knee that awoke him from sleep. He has a history of ischemic cardiomyopathy with a left ventricular ejection fraction of $30\%$ , chronic kidney disease with a baseline serum creatinine of $2.7 \text{ mg/dL}$ , and a recent diagnosis of atypical community-acquired pneumonia for which he began taking clarithromycin $3$ days ago. His temperature is $37.2^{\circ}\text{C}$ ( $99.0^{\circ}\text{F}$ ), blood pressure is $118/76 \text{ mm Hg}$ , and pulse is $82/\text{min}$ . Physical examination shows a warm, erythematous, and exquisitely tender left knee with a moderate effusion. Arthrocentesis is performed, yielding synovial fluid with a leukocyte count of $35,000/\mu\text{L}$ ( $90\%$ neutrophils). Polarized light microscopy reveals needle-shaped, negatively birefringent crystals. Gram stain shows no organisms. Which of the following is the most appropriate pharmacologic intervention for this patient's current joint condition?

Oral prednisoneAnswer
B
Oral colchicine
C
Oral naproxen
D
Oral allopurinol
E
Intravenous ceftriaxone and vancomycin

Answer

Oral prednisone

Oral prednisone is the most appropriate treatment for this patient's acute gout flare. While NSAIDs, colchicine, and corticosteroids are all first-line agents for acute gout, therapeutic selection is driven by patient comorbidities. This patient's advanced chronic kidney disease and ischemic cardiomyopathy preclude the use of NSAIDs. Furthermore, his concurrent use of clarithromycin (a strong CYP3A4 and P-glycoprotein inhibitor) acts as an absolute contraindication to colchicine, as their interaction can precipitate fatal colchicine toxicity. Therefore, systemic corticosteroids (or intra-articular injection) represent the safest and most effective remaining option.

Step-by-Step Solution

Interpret the synovial fluid analysis to establish a definitive diagnosis.

The presence of negatively birefringent, needle-shaped crystals confirms an acute gouty flare, ruling out septic arthritis despite the elevated leukocyte count.

Accurate diagnosis dictates the therapeutic pathway, shifting focus from empiric antibiotics to anti-inflammatory management.

Evaluate the patient's comorbidities against standard first-line therapies for acute gout.

The patient has advanced chronic kidney disease and heart failure with reduced ejection fraction, which represent absolute contraindications to nonsteroidal anti-inflammatory drugs (NSAIDs).

NSAIDs can precipitate acute renal failure in pre-existing CKD and worsen fluid retention in heart failure.

Assess the patient's current medication list for potential drug-drug interactions with gout therapies.

The patient is taking clarithromycin, a potent inhibitor of both CYP3A4 and P-glycoprotein.

Colchicine is metabolized by CYP3A4 and requires P-glycoprotein for efflux; co-administration with clarithromycin can lead to fatal colchicine toxicity (severe neuromyopathy, bone marrow suppression), especially in the setting of renal impairment.

Select the safest remaining therapeutic option.

Oral prednisone (or intra-articular corticosteroids) is chosen.

Systemic corticosteroids effectively treat acute gout flares and avoid the renal, hemodynamic, and pharmacokinetic contraindications present in this patient.

Key Concept

Management of acute gout flares in patients with significant comorbidities and drug-drug interactions.

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic